The FDA is taking another look at premium cigars in a move that anti-tobacco groups fear could weaken regulations. It's the latest push under Commissioner Scott Gottlieb to undertake a sweeping overall of tobacco and nicotine regulation. The FDA recently took the first step in lowering the amount of nicotine in cigarettes. It also said it's seeking information on the role flavors, including menthol, play in attracting people to tobacco products and alternatives like e-cigarettes.
On April 24, 2014, the U.S. Food and Drug Administration (FDA) released proposed regulations to extend the authority of the FDA's Center for Tobacco Products (CTP), under the Family Smoking Prevention and Tobacco Control Act, to additional tobacco products. This can have a major impact on the cigar industry along with the other tobacco products that the FDA is targeting.
IPCPR has launched a new grassroots website, cigaraction.org. This site is a resource for retailers and consumers to get involved with public policy issues that affect premium cigars. This launch coincides with their first grassroots campaign urging Congress to support a premium cigar exemption provision in the annual spending bill. Over time, this site will serve as the center of IPCPR’s grassroots effort with the cigar community for multiple federal and state initiatives.
Today President Trump announced Dr. Scott Gottlieb as his pick to lead the Food & Drug Administration (FDA). Dr. Gottlieb has an impressive and extensive resume, with a wide-ranging background in both the private and public sectors and a M.D. from Mount Sinai School of Medicine. IPCPR welcomes the pick of Dr. Gottlieb and, If confirmed, we look forward to working with him as we continue to advocate for common-sense reforms to the recent FDA regulation needlessly harming the family owned small businesses retailers that make up IPCPR.
This week the FDA announced a six-month extension of the ingredient listing requirement for manufacturers and importers of newly “deemed”...
Earlier today the US House of Representatives passed a 12 bill spending package that includes a provision prohibiting the FDA from enforcing regulations against premium cigars. The bill, known as an omnibus appropriations package, passed the House by 211-198 votes and will now move to the Senate for consideration. Congress has until December 8th to pass spending legislation and fund the federal government.
WASHINGTON, June 24 (Reuters) - White House changes to proposed rules for tobacco products significantly weakened language detailing health risks from cigars and deleted restrictions that might have prevented online sales of e-cigarettes, published documents show.
I thought I would take an opportunity to put down some of my thoughts and observations from the IPCRPR 2014 show that was held in Las Vegas this past week. Just to be clear, these are my thoughts and opinions and do not necessarily reflect those of Blind Man's Puff or any other member of the team here.
The U.S. Food and Drug Administration on Thursday decided to choose Option 1 of the two proposed regulations on tobacco products, option 2 would have granted an exemption for premium cigars. Today, the FDA banned sales of e-cigarettes, cigars, pipe tobacco and hookah tobacco to people under age 18, in line with cigarette rules, a move aimed at preventing a new generation from becoming addicted to nicotine. The agency said it also will require companies to submit these products to it for regulatory review, provide it with a list of product ingredients and place health warnings on their product packages and in advertisements.